PeptiDream and J&J ink billion-dollar drug discovery deal

This article was originally published here

Japan’s PeptiDream has once again turned small molecules into big business, signing a drug discovery agreement with Johnson & Johnson that could be worth up to $1.15 billion.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply